Detailseite
Prof. Dr. med. Wulf Siggelkow
Chefarzt
Tel: 0511 289-3281/129-2310
Fax:
Publikationen
- Publikationen Prof. Dr. med. Wulf Siggelkow
-
I. wissenschaftliche Publikationen
1. Siggelkow W, Faridi A, Spiritus K, Klinge U, Rath W, Klosterhalfen B. Histological analysis of silicone breast implant capsules and correlation with capsular contracture.
Biomaterials. 2003; 24(6):1101-9
2. Siggelkow W, Zimny M, Faridi A, Petzold K, Buell U, Rath W. The value of Positron Emission Tomography in the follow-up for breast cancer.
Anticancer Research, 2003; 23(2C):1859-67
3. Siggelkow W, Klosterhalfen B, Klinge U, Rath W, Faridi A. An analysis, made at explantation, of local complications relating to silicone breast implants.
The Breast, 2004; 13(2): 122-8
4. Siggelkow W, Faridi A, Klinge U, Rath W, Klosterhalfen B. Ki67, HSP70 and TUNEL for Specification of Testing of Silicone Breast Implants in vivo.
J Mater Sci Mater Med. 2004;15(12):1355-60
5. Siggelkow W, Gescher DM, Siggelkow A, Rath W, Klee, D, Faridi A. In vitro analysis of modified silicone breast implants. Int J Artif Org, 2004; 27(12):1100-8
6. Siggelkow W, Heinrichs U, Spritus K, Klosterhalfen B, Rath W, Faridi A. Histologische Befunde an Silikonimplantat-Kapseln der Brust in Abhängigkeit von der Implantat-Liegezeit. Geburtsh Frauenheilk, 2004; 64: 612-17
7. Siggelkow W, Zimny M, Faridi A, Petzold K, Malik E, Rath W. Die Wertigkeit der Positronen-Emissionstomographie bei Tumormarkerprogression in der Nachsorge Ovarialkarzinoms. Geburtsh Frauenheilk 2004; 64:178-82
8. Siggelkow W, Rath W, Büll U, Zimny M. FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
Eur J Nucl Med, 2004; 31(1): 118-24.
9. Siggelkow W, Rath W, Faridi A. Modifizierte Dual-plane Implantatposition zur operativen Behandlung der Kapselkontraktur nach präpektoraler Brustaugmentationen. Gebrutsh Frauenheilk 2005; 65: 1-6
10. Siggelkow W , Lebrecht A, Kölbl H, Faridi A. Dual-Plane implant- positioning for capsular contracture of the breast in combination with mastopexy.
Arch Gynecol Obstet. 2005; 273(2):79-85.
11. Siggelkow W, Boehm D, Skala C, Grosslercher M, Schmidt M, Koelbl H. The influence of macrosomia on the duration of labor, the mode of delivery and intrapartum complications. Arch Gynecol Obstet. 2008; 278(6):547-53
12. Siggelkow W, Schmidt M, Skala C, Boehm D, von Forstner S, Koelbl H, Tresch A. A new algorithm for improving fetal weight estimation from ultrasound data at term. Arch Gynecol Obstet 2011; 283(3):469-74
13. Siggelkow W, Lübbe K, Gade J, Kölbl H, Schmidt M, Böhm D. Skin-reducing Mastectomy with Primary Implant Reconstruction. Geburtsh Frauenheilk 2012; 72: 616–621
14. Siggelkow W, Böhm D, Gebhard S, Battista M, Sicking I, Lebrecht A, Solbach C, Hellwig B, Rahnenführer J, Koelbl H, Gehrmann M, Marchan R, Cadenas C, Hengstler JG, Schmidt M, Expression of aurora kinase A is associated with 3 metastasis-free survival in node-negative breast cancer patients. BMC Cancer 2012, 12:562
15. Siggelkow W, Schwarz N, Beckmann MW, Schild RL, Comparison of obstetric efficacy and safety with the Kiwi OmniCup and conventional vacuum extraction. Arch Geburtsh Frauenheilk 2014
16. Zimny M, Siggelkow W, Nowak B, Schröder W, Biemann S, Rath W, Büll U. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the diagnosis of recurrent ovarian cancer.
Gynecol Oncol 2001; 83(2):310-5
17. Faridi A, Willis S, Schelzig P, Siggelkow W, Schumpelick V, Rath W. Anal sphincter injury during vaginal delivery-an argument for caesarian sectio on request?
J Perinat Med 2002; 30:379-387
18. Gescher DM, Siggelkow W, Meyhoefer-Malik, A, Malik E. A priori implantation potential does not differ in eutopic endometrium of patients with and without endometriosis. Arch Gynecol Obstet. 2005; 272(2):117-23
19. Hansen T, Wulgaris S, Siggelkow W, Kölbl H, Kirkpatrick CJ. Massive adenomyosis in a patient with uterus septus completus. Zentralbl Gynakol. 2006 Jun;128(3):153-6
20. Boehm DU, Lebrecht A, Schmidt M, Siggelkow W, Lindner C, Litz A, Ulbrich E, Koelbl H. Prognostic impact of haemoglobin levels in breast cancer. Anticancer Res. 2007;27(2):1223-6
21. Boehm DU, Lebrecht A, Maltaris T, Schmidt M, Siggelkow W, Fischer S, Kandelhart E, Koelbl H. Influence of resection volume on locoregional recurrence
of breast cancer after breast-conserving surgery. Anticancer Res. 2008; 28(2B):1207-
22. Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann
M, Lehr HA, Koelbl H, Hengstler JG, Schuler M. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res. 2008 15;14(18):5849-55
23. Boehm DU, Lebrecht A, Eckhardt T, Albrich S, Schmidt M, Siggelkow W, Kandelhardt E, Koelbl H. Quality of life and adjuvant tamoxifen treatment in breast cancer patients. Eur J Cancer Care 2009;18(5):500-6.
24. Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsässer A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C. Long-term outcome prediction by clinicopathological risk
classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol. 2009;20(2):258-64
25. Böhm D, Keller K, Pieter J, Boehm N, Wolters D, Siggelkow W, Lebrecht A, Schmidt M, Kölbl H, Pfeiffer N, Grus FH. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncolgy Reports 2012; 28: 429-438
Übersichtsarbeiten/ Leitlinienpapiere:
1. Siggelkow W, Kölbl H. Herausforderung Altersgynäkologie. Frauenarzt 2007; 48:140-145
2. Siggelkow W, Böhm D, Kölbl H. Medikamentöse Primärtherapie des Ovarialkarzinoms. Frauenarzt 2008; 49: 918-921
3. Schmidt-Rhode P, Dieterich H, Siggelkow W. Zur Sicherheit von Silikon-Brustimplantaten. Leitlinie der DGGG. Aktualisiert 2008 und 2010. www.dggg.de
4. Zimny M, Siggelkow W. Positron emission tomography scanning in gynaecologic and breast cancers. Curr Opin Obstet Gynecol 2003; 15(1): 69-75 zum Download